Does Immune Therapy Help Smokers With Lung Cancer?
Siddhartha Mukherjee says immune therapy is now known to extend the lifespan of smokers with lung cancer if it is given to the right population of people. Fifteen years ago he wrote a personal note to himself saying he would not live to a time when a medicine would potentially extend the lifetime of a smoker with lung cancer. He says the note is no longer true.
He places the result in the last 15 years, when immunotherapy, which he describes as activating the immune system, has been extremely productive against some cancers. The lung cancer example is the one he gives. The drugs unveil or unleash the immune system to recognize cancers as foreign cells and enable treatment of cancers.
The change he describes is specific. Immune therapy can extend lifespan for smokers with lung cancer only in the right population of people, by letting the immune system treat cancers as foreign cells.
From the transcript
In the realm of treatment, there's lots of things. We know since the last 15 years that immunotherapy, activating the immune system, is extremely productive against some cancers. Just to give you one example, I had sort of written a personal note to myself saying that this was 15 years ago, that I would not live to a time where there would be a medicine that would potentially extend the lifetime of a smoker with lung cancer.
That's not true anymore. Immune therapy is now known to extend the lifespan of smokers with lung cancer if given to the right population of people. These are drugs that unveil or unleash the immune system to recognize cancers as foreign cells and enable treatment of cancers. We know that in some cases, activated T cells, genetically engineered T cells, so -called CAR T cells, can cure liquid cancers such as leukemias, blood cancers, such as leukemias and lymphomas.